FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 11/10/2010 |
3. Issuer Name and Ticker or Trading Symbol
COMPLETE GENOMICS INC [ GNOM ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stcok, $0.001 par value | 405,542 | I | See Footnote (4) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Series B Preferred Stock(1) | (2) | (3) | Common Stock | 601,248 | $0.00 | I | See Footnote(4) |
Series C Preferred Stock(5) | (2) | (3) | Common Stock | 160,552 | $0.00 | I | See Footnote(4) |
Series D Preferred Stock(6) | (2) | (3) | Common Stock | 674,426 | $0.00 | I | See Footnote(4) |
Series E Preferred Stock(6) | (2) | (3) | Common Stock | 807,760 | $0.00 | I | See Footnote(4) |
Warrant to Purchase Common Stock | (7) | 04/12/2015 | Common Stock | 133,938 | $1.5 | I | See Footnote(4) |
Warrant to Purchase Common Stock | (7) | 06/22/2015 | Common Stock | 51,959 | $1.5 | I | See Footnote(4) |
Warrant to Purchase Series D Preferred Stock(6) | (7) | 02/13/2014 | Common Stock | 29,343 | $7.56 | I | See Footnote(4) |
Warrant to Purchase Series D Preferred Stock(6) | (7) | 04/06/2014 | Common Stock | 31,299 | $7.56 | I | See Footnote(4) |
Warrant to Purchase Series D Preferred Stock(6) | (7) | 06/12/2014 | Common Stock | 10,240 | $7.56 | I | See Footnote(4) |
Warrant to Purchase Series D Preferred Stock(6) | (7) | 08/05/2014 | Common Stock | 990 | $7.56 | I | See Footnote(4) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. Each share of Series B Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 5.926613 conversion ratio applicable to such shares. |
2. The securities are immediately convertible. |
3. The expiration date is not relevant to the conversion of these securities. |
4. The shares are owned by Prospect Venture Partners III, L.P. ("PVP III"). Prospect Management Co. III, L.L.C. ("PMC III") serves as the general partner of PVP III and possesses sole voting and investment control over the shares owned by PVP III and may be deemed to have indirect beneficial ownership of the shares held by PVP III. PMC III however owns no securities of the Issuer directly. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein. |
5. Each share of Series C Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 8.241076 conversion ratio applicable to such shares. |
6. Each share of Series D and Series E Preferred Stock will automatically convert on a 1-for-1 basis into common stock upon the closing of the Issuer's initial public offering. |
7. The warrant is immediately exercisable. |
/s/ Managing Director, Prospect Management Co. III LLC, its General Partner, PROSPECT VENTURE PARTNERS III. L.P. | 11/10/2010 | |
/s/ Managing Director, PROSPECT MANAGEMENT CO. II, LLC | 11/10/2010 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |